Form 4: Cardlytics CFO Alexis DeSieno Reports Stock Transactions

Cardlytics' Chief Financial Officer, Alexis DeSieno, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On October 1, 2024, Alexis DeSieno, the CFO of Cardlytics, Inc., had 14,350 restricted stock units (RSUs) vest.
• These RSUs represent a contingent right to receive one share of Cardlytics common stock each.
• Following the vesting, Ms. DeSieno sold 7,487 shares of common stock on October 2, 2024, at a weighted average price of $3.085 per share.
• The sales were solely to cover tax withholding obligations resulting from the RSU vesting.
• After these transactions, Ms. DeSieno directly owns 97,849 shares of Cardlytics common stock and 86,097 restricted stock units.
• The RSUs vest in eight equal installments quarterly.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, as it's a factual report of transactions.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover tax obligations upon vesting of RSUs is a common practice.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the relatively small volume of shares sold.

Key Dates